Overview

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients

Status:
Completed

Trial end date:
2012-06-06

Target enrollment:

Participant gender:

Summary

This study is to evaluate long-term safety and efficacy after concomitant administration of ASP1941 and DPP-4 inhibitor in Japanese patients with type 2 diabetes mellitus.

Phase:

Phase 3

Details

Lead Sponsor:

Astellas Pharma Inc

Treatments:

Alogliptin
Dipeptidyl-Peptidase IV Inhibitors
Ipragliflozin
Saxagliptin
Sitagliptin Phosphate
Vildagliptin